Document is current
Any future updates will be listed below
-
Authors
Wang, Li
Sebra, Robert P.
Sfakianos, John P.
Allette, Kimaada
Wang, Wenhui
Yoo, Seungyeul
Bhardwaj, Nina
Schadt, Eric E.
Yao, Xin
Galsky, Matthew D.
-
Funding
Funding for this research was provided by:
National Institutes of Health (U19 AI118610)
- License Information
-
More Information
Article History
Received: 29 May 2019
Accepted: 3 February 2020
First Online: 28 February 2020
Ethics approval and consent to participate
: Tumor specimens utilized to generate single-cell RNA sequencing data were derived from patients participating in project #10-1180 approved by the Icahn School of Medicine Institutional Review Board. Written informed consent was obtained from participants. The research conformed to the Declaration of Helsinki.
: Not applicable.
: N.B. is on SAB of Curevac, Checkpoint Sciences, Tempest Therapeutics, and Neon, and consults for Genentech, and receives research support from Merck and Regeneron. L.W., R.S., E.S., and J. Z. are affiliated with Sema4. The remaining authors declare that they have no competing interests.
